UCL Study Links Gut Microbes to Early Parkinson’s Risk
SkimNews Take
The identification of a universal gut-microbe signature for Parkinson's suggests a consistent biological pathway for the disease across diverse populations, independent of local environmental or dietary factors.
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- UCL conducted a study of 271 Parkinson’s patients, 43 genetically at‑risk individuals, and 150 healthy controls to identify a gut microbiome signature.
- Anthony Schapira led the analysis that found 176 gut microbial species differed in abundance between Parkinson’s patients and healthy subjects.
- Nature Medicine published corroborating data from 638 Parkinson’s patients and 319 controls across the UK, South Korea, and Turkey, confirming the signature’s consistency.
- UK participants showed that a small subset of healthy adults carried the same microbiome pattern, indicating potential future risk.
- South Korea contributed data that reinforced the microbiome signature across diverse populations.
- Turkey added further evidence that the microbial changes are present in patients from different regions.
Why it matters: Neurologists gain a screening method that flags at‑risk adults among the 8.5 million worldwide Parkinson’s patients, while drug makers lose sales of late‑stage therapies; early detection cuts future healthcare costs by billions.
